India, Nov. 12 -- Novo Nordisk A/S has cut the prices its weight-loss drug Wegovy by up to 37% in India, as the Danish drugmaker looks to hold its own against Eli Lilly & Co.'s Mounjaro in a country that's home to the third largest obesity population in the world.

The monthly price for Wegovy's highest dose of 2.4 mg will now cost Rs.16,400, compared with its earlier price of Rs.24,389.06, according to the document that Novo Nordisk sent to its distributors in India. Reuters has seen a copy of the document. Its lowest dose of 0.25 mg will sell at Rs.10,850 for a monthly pack, compared with Rs.16,260.94 earlier.

The price cut includes the impact of GST 2.0.

"We have made sure to listen to our patient and doctor communities and take acti...